Table 1 Demographic, clinical and laboratory characteristics of the patient and control groups
Parameters | Patients (n = 186) | Control (n = 171) | p |
|---|---|---|---|
Mean age (years) | 29.30 ± 5.45 | 28.77 ± 5.44 | 0.360 |
Gender (n, %) | |||
Female | 133 (71.5) | 124 (72.5) | 0.832 |
Male | 53 (28.5) | 47 (27.5) | |
BMI (kg/m2) | 25.94 ± 2.84 | 26.02 ± 2.86 | 0.795 |
Hgb (g/dL) | 12.68 ± 0.6 | 12.66 ± 0.6 | 0.538 |
Wbc (×103/mL) | 5.9 ± 1.17 | 4.46 ± 1.17 | 0.190 |
Urea (mg/dL) | 18.55 ± 4.91 | 18.60 ± 4.95 | 0.927 |
GFR (ml/min) | 106 ± 7 | 101 ± 9 | 0.206 |
ESR (mm/h) | 4.96 ± 1.44 | 4.97 ± 1.45 | 0.929 |
CRP (mg/L) | 0.71 ± 0.3 | 0.7 ± 0.3 | 0.725 |
Smoking (n, %) | 41 (22) | 38 (22.2) | 0.967 |
Disease duration (years) | 6.98 ± 3.87 | ||
Attack frequency (n, %) | |||
1–5/month | 114 (61.3) | ||
6–10/month | 56 (30.1) | ||
> 10/month | 16 (8.6) | ||
MIDAS score | 2.86 ± 1.12 | ||
Vomiting | 99 (52.3) | ||
FF | 143 (76.8) | ||
Mood changes | 132 (70.9) | ||